.Attributes Medicine, Released online: 03 September 2024 doi:10.1038/ s41591-024-03223-zThis Standpoint calls for incorporation of clients with MASLD and size of liver end results in cardio-- kidney-- metabolic tests, when information advise mechanistically probable benefits and also medical protection-- and also describes points to consider for trial design as well as governing approval.